Restoration of ARID1A Protein in ARID1A-deficient Clear Cell Carcinoma of the Ovary Attenuates Reactivity to Cytotoxic T Lymphocytes.
Risa TsunematsuAiko MuraiYuka MizueTerufumi KuboTasuku MariyaRena MoritaKenji MurataTakayuki KanasekiTomohide TsukaharaYoshihiko HirohashiTsuyoshi SaitoToshihiko TorigoePublished in: Cancer genomics & proteomics (2024)
Cancer immunotherapy is an effective approach to target ARID1A-deficient clear cell carcinoma of the ovary.
Keyphrases